This is your local chapter! Reset >
Set this as your local chapter! Set >
News Events About Us Find Help Get Involved Follow Us
Home > Connecticut > LFACT President & CEO Michael Tommasi PSA
Here is a PSA from LFACT President & CEO Michael Tommasi!
Facebook Twitter Email Print
Lupuzor a new lupus drug currently in clinical trials has been put on fast track status by the FDA.
On June 25, 250 lupus activists presented a petition with over 30,000 to Congress urging them to support expanded lupus research. Learn more!
Check out this fantastic video from our West Hartford Walk to End Lupus Now!